Interim data from the Medical Research Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer?
Authors
Langley, R EStephens, R J
Nankivell, M
Pugh, C
Moore, B
Navani, N
Wilson, P
Faivre-Finn, Corinne
Barton, R
Parmar, M K B
Mulvenna, P M
Affiliation
MRC Clinical Trials Unit, London, UKIssue Date
2013-03
Metadata
Show full item recordAbstract
Over 30% of patients with non-small cell lung cancer (NSCLC) develop brain metastases. If inoperable, optimal supportive care (OSC), including steroids, and whole brain radiotherapy (WBRT) are generally considered to be standard care, although there is no randomised evidence demonstrating that the addition of WBRT to OSC improves survival or quality of life.Citation
Interim data from the Medical Research Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer? 2013, 25 (3):e23-30 Clin Oncol (R Coll Radiol)Journal
Clinical OncologyDOI
10.1016/j.clon.2012.11.002PubMed ID
23211715Type
ArticleLanguage
enISSN
1433-2981ae974a485f413a2113503eed53cd6c53
10.1016/j.clon.2012.11.002